InsiderSignal.AI

InsiderSignal.ai

BDSX - Biodesix Inc

Insider Purchase by Schuler Jack W (Emeritus Director, 10%)

3 Months
After Trade
Before Trade

Loading data...

Trade Summary

1 month ago, Schuler Jack W, serving as Emeritus Director, 10% owner at Biodesix Inc (BDSX), purchased 100,000 shares at $11.81 per share, for a total transaction value of $1,180,736.00. Following this transaction, Schuler Jack W now holds 2,313,210 shares of BDSX.

This purchase represents a 5.00% increase in Schuler Jack W's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, January 23, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, January 27, 2026, 4 days after the trade was made.

Biodesix Inc operates in the HEALTHCARE sector, specifically within the DIAGNOSTICS & RESEARCH industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Schuler Jack W

Emeritus Director, 10%

Jack W. Schuler is a seasoned healthcare executive and investor who served as a Director of Biodesix Inc. (NASDAQ: BDSX) from June 2008 until transitioning to Board Emeritus in May 2025.[[3]](https://www.biodesix.com/company/leadership)[[4]](https://investors.biodesix.com/static-files/3d5caf6d-e06a-4ec4-accc-115037fed85a) In this role, he demonstrated strong confidence in the company's future through substantial personal investments, including purchases of over 4.7 million shares for approximately $1.32 million in May 2025 amid a stock price decline, and 100,000 shares for $122,840 in November 2024, increasing his indirect holdings via the Jack W. Schuler Living Trust to over 31 million shares.[[1]](https://www.waiker.ai/data-lab/waiker-news/4623)[[2]](https://www.investing.com/news/insider-trading-news/biodesix-director-jack-schuler-buys-122840-in-stock-93CH-3737750) Schuler's distinguished career spans decades in diagnostics and medical devices. He was President and Chief Operating Officer of Abbott Laboratories, joining in 1972 and advancing through management and marketing roles, while serving as a director from 1985 to 1989.[[3]](https://www.biodesix.com/company/leadership) He chaired Ventana Medical Systems from 1995 until its 2008 acquisition by Roche, having joined its board in 1991.[[3]](https://www.biodesix.com/company/leadership) A founding partner of private investment firm Crabtree Partners, he has held directorships at Medtronic (Lead Director), Stericycle (Chairman), Quidel Corporation, Accelerate Diagnostics, and others.[[3]](https://www.biodesix.com/company/leadership)[[6]](https://acceleratediagnostics.com/inside-accelerate/board-of-directors/) Schuler holds a B.S. in Mechanical Engineering from Tufts University and an M.B.A. from Stanford Graduate School of Business.[[3]](https://www.biodesix.com/company/leadership)

View full insider profile →

Trade Price

$11.81

Quantity

100,000

Total Value

$1,180,736.00

Shares Owned

2,313,210

Trade Date

Friday, January 23, 2026

30 days ago

SEC Filing Date

Tuesday, January 27, 2026

Filed 4 days after trade

HEALTHCAREDIAGNOSTICS & RESEARCH

About Biodesix Inc

Company Overview

No company information available
View news mentioning BDSX

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/3467035

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime